AU5101801A - Inhibition of angiogenesis and tumor growth - Google Patents

Inhibition of angiogenesis and tumor growth

Info

Publication number: AU5101801A
Authority: AU; Australia
Prior art keywords: angiogenesis; inhibition; tumor growth; tumor; growth
Prior art date: 2000-03-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

AU5101801A

Inventor

Dale L Boger

David A Cheresh

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Scripps Research Institute

Original Assignee

Scripps Research Institute

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-27

Filing date

2001-03-27

Publication date

2001-10-08

2001-03-27 Application filed by Scripps Research Institute filed Critical Scripps Research Institute

2001-10-08 Publication of AU5101801A publication Critical patent/AU5101801A/en

Status Pending legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Pain & Pain Management (AREA)
Emergency Medicine (AREA)
Rheumatology (AREA)
Vascular Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Hydrogenated Pyridines (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU5101801A 2000-03-27 2001-03-27 Inhibition of angiogenesis and tumor growth Pending AU5101801A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US19226000P	2000-03-27	2000-03-27
PCT/US2001/009756 WO2001072699A1 (en)	2000-03-27	2001-03-27	Inhibition of angiogenesis and tumor growth

Publications (1)

Publication Number	Publication Date
AU5101801A true AU5101801A (en)	2001-10-08

Family

ID=22708924

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
AU5101801A Pending AU5101801A (en)	2000-03-27	2001-03-27	Inhibition of angiogenesis and tumor growth
AU2001251018A Ceased AU2001251018B2 (en)	2000-03-27	2001-03-27	Inhibition of angiogenesis and tumor growth
AU4949901A Pending AU4949901A (en)	2000-03-27	2001-03-27	Methods for inhibiting angiogenesis and tumor growth
AU2001249499A Ceased AU2001249499B2 (en)	2000-03-27	2001-03-27	Methods for inhibiting angiogenesis and tumor growth

Family Applications After (3)

Application Number	Title	Priority Date	Filing Date
AU2001251018A Ceased AU2001251018B2 (en)	2000-03-27	2001-03-27	Inhibition of angiogenesis and tumor growth
AU4949901A Pending AU4949901A (en)	2000-03-27	2001-03-27	Methods for inhibiting angiogenesis and tumor growth
AU2001249499A Ceased AU2001249499B2 (en)	2000-03-27	2001-03-27	Methods for inhibiting angiogenesis and tumor growth

Country Status (15)

Country	Link
EP (2)	EP1276713A4 (en)
JP (2)	JP2003528850A (en)
KR (2)	KR100767616B1 (en)
CN (2)	CN1229339C (en)
AU (4)	AU5101801A (en)
CA (3)	CA2659030A1 (en)
CZ (2)	CZ20023510A3 (en)
HU (2)	HUP0301797A3 (en)
MX (2)	MXPA02009510A (en)
NO (2)	NO328969B1 (en)
PL (2)	PL358272A1 (en)
RU (2)	RU2276133C2 (en)
SK (2)	SK14852002A3 (en)
WO (2)	WO2001072297A1 (en)
ZA (2)	ZA200208626B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2315721T5 (en)	2003-10-23	2012-08-24	Otsuka Pharmaceutical Co., Ltd.	Formulation of sterile controlled-release injectable aripiprazole and procedure
LT2170279T (en)	2007-07-31	2018-03-12	Otsuka Pharmaceutical Co., Ltd.	Methods for producing aripiprazole suspension and freeze-dried formulation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8311286D0 (en) *	1983-04-26	1983-06-02	Searle & Co	Carboxyalkyl peptide derivatives
JPH05125029A (en) *	1991-11-06	1993-05-21	Yamanouchi Pharmaceut Co Ltd	New amide compound or its salt
GB9308695D0 (en) *	1993-04-27	1993-06-09	Celltech Ltd	Peptidyl derivatives
GB9405076D0 (en) *	1994-03-16	1994-04-27	Inst Of Ophtalmology	A medical use of matrix metalloproteinase inhibitors
AUPO104496A0 (en) *	1996-07-17	1996-08-08	Biomolecular Research Institute Limited	Angiogenic inhibitory compounds
US6294674B1 (en) *	1996-09-04	2001-09-25	Warner-Lambert Company	Dibenzofuran sulfonamide matrix metalloproteinase inhibitors
CA2279869A1 (en) *	1997-02-07	1998-08-13	Dale L. Boger	Convergent synthesis of combinatorial library
EP1063982B1 (en) *	1998-03-27	2007-02-14	Genentech, Inc.	Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders

2001
- 2001-03-27 EP EP01924359A patent/EP1276713A4/en not_active Ceased
- 2001-03-27 AU AU5101801A patent/AU5101801A/en active Pending
- 2001-03-27 CZ CZ20023510A patent/CZ20023510A3/en unknown
- 2001-03-27 CA CA002659030A patent/CA2659030A1/en not_active Abandoned
- 2001-03-27 CN CNB018097448A patent/CN1229339C/en not_active Expired - Fee Related
- 2001-03-27 MX MXPA02009510A patent/MXPA02009510A/en active IP Right Grant
- 2001-03-27 WO PCT/US2001/009785 patent/WO2001072297A1/en active IP Right Grant
- 2001-03-27 WO PCT/US2001/009756 patent/WO2001072699A1/en active IP Right Grant
- 2001-03-27 PL PL01358272A patent/PL358272A1/en not_active Application Discontinuation
- 2001-03-27 HU HU0301797A patent/HUP0301797A3/en unknown
- 2001-03-27 CN CNB01809743XA patent/CN1245967C/en not_active Expired - Fee Related
- 2001-03-27 RU RU2002128751/04A patent/RU2276133C2/en not_active IP Right Cessation
- 2001-03-27 JP JP2001570612A patent/JP2003528850A/en active Pending
- 2001-03-27 SK SK1485-2002A patent/SK14852002A3/en not_active Application Discontinuation
- 2001-03-27 KR KR1020027012724A patent/KR100767616B1/en not_active IP Right Cessation
- 2001-03-27 KR KR1020027012720A patent/KR100776185B1/en not_active IP Right Cessation
- 2001-03-27 RU RU2002128736/15A patent/RU2269339C2/en not_active IP Right Cessation
- 2001-03-27 JP JP2001570258A patent/JP2003528140A/en not_active Withdrawn
- 2001-03-27 SK SK1484-2002A patent/SK14842002A3/en not_active Application Discontinuation
- 2001-03-27 AU AU2001251018A patent/AU2001251018B2/en not_active Ceased
- 2001-03-27 CA CA2403871A patent/CA2403871C/en not_active Expired - Fee Related
- 2001-03-27 MX MXPA02009504A patent/MXPA02009504A/en active IP Right Grant
- 2001-03-27 CA CA002403630A patent/CA2403630C/en not_active Expired - Fee Related
- 2001-03-27 AU AU4949901A patent/AU4949901A/en active Pending
- 2001-03-27 HU HU0301621A patent/HUP0301621A3/en unknown
- 2001-03-27 PL PL366316A patent/PL205134B1/en not_active IP Right Cessation
- 2001-03-27 CZ CZ20023509A patent/CZ20023509A3/en unknown
- 2001-03-27 AU AU2001249499A patent/AU2001249499B2/en not_active Ceased
- 2001-03-27 EP EP01922734A patent/EP1272173A4/en not_active Withdrawn
2002
- 2002-09-24 NO NO20024578A patent/NO328969B1/en not_active IP Right Cessation
- 2002-09-24 NO NO20024576A patent/NO20024576L/en not_active Application Discontinuation
- 2002-10-24 ZA ZA200208626A patent/ZA200208626B/en unknown
- 2002-10-24 ZA ZA200208628A patent/ZA200208628B/en unknown

Also Published As

Publication number	Publication date
KR100776185B1 (en)	2007-11-16
WO2001072297A1 (en)	2001-10-04
EP1272173A1 (en)	2003-01-08
RU2269339C2 (en)	2006-02-10
EP1276713A1 (en)	2003-01-22
CN1245967C (en)	2006-03-22
NO328969B1 (en)	2010-06-28
MXPA02009510A (en)	2003-05-21
CN1429106A (en)	2003-07-09
PL358272A1 (en)	2004-08-09
CA2403871C (en)	2010-05-11
KR100767616B1 (en)	2007-10-18
PL366316A1 (en)	2005-01-24
HUP0301621A2 (en)	2003-09-29
JP2003528140A (en)	2003-09-24
CN1229339C (en)	2005-11-30
WO2001072699A1 (en)	2001-10-04
CZ20023509A3 (en)	2003-06-18
ZA200208628B (en)	2004-02-12
CA2403630A1 (en)	2001-10-04
AU4949901A (en)	2001-10-08
CZ20023510A3 (en)	2003-03-12
KR20020091156A (en)	2002-12-05
SK14842002A3 (en)	2003-04-01
SK14852002A3 (en)	2003-06-03
AU2001249499B2 (en)	2005-04-21
NO20024576D0 (en)	2002-09-24
HUP0301621A3 (en)	2009-06-29
ZA200208626B (en)	2004-02-16
EP1276713A4 (en)	2006-05-03
JP2003528850A (en)	2003-09-30
HUP0301797A3 (en)	2010-09-28
NO20024578D0 (en)	2002-09-24
EP1272173A4 (en)	2006-05-03
CA2403630C (en)	2009-05-26
PL205134B1 (en)	2010-03-31
AU2001251018B2 (en)	2005-12-01
CN1441777A (en)	2003-09-10
MXPA02009504A (en)	2003-05-21
KR20020084258A (en)	2002-11-04
RU2276133C2 (en)	2006-05-10
NO20024578L (en)	2002-11-20
HUP0301797A2 (en)	2003-09-29
CA2403871A1 (en)	2001-10-04
RU2002128751A (en)	2004-03-10
NO20024576L (en)	2002-11-20
CA2659030A1 (en)	2001-10-04

Publication	Publication Date	Title
EP1097165A4 (en)	2001-09-12	Novel inhibitors of angiogenesis and tumor growth
AU2001296558A1 (en)	2002-04-15	Inhibitors of angiogenesis and tumor growth for local and systemic administration
AU2001256975A1 (en)	2001-10-15	Compositions and methods for inhibition of cancer invasion and angiogenesis
AU6147401A (en)	2001-11-26	Compositions and methods for the treatment of cancer
IL178864A0 (en)	2007-03-08	3'-prodrugs of 2'-deoxy-??-l-nucleosides
AU2600800A (en)	2000-09-28	Promotion or inhibition of angiogenesis and cardiovascularization
EP1320376A4 (en)	2005-06-15	Treatment of prostate cancer
EP1083928A4 (en)	2002-05-22	Method of inhibiting angiogenesis and tumor growth and preventing tumor growth and metastases
AU2596700A (en)	2000-09-28	Promotion or inhibition of angiogenesis and cardiovascularization
EP1294949A4 (en)	2004-08-25	Human tumor necrosis factor delta and epsilon
HUP0300873A3 (en)	2006-02-28	Stereoselective reduction of substituted oxo-butanes
AU5000001A (en)	2001-09-03	Treatment of vitiligo
HRP20020729A2 (en)	2004-02-29	Treatment of psoriasis
AU5101801A (en)	2001-10-08	Inhibition of angiogenesis and tumor growth
HK1053825B (en)	2005-08-19	Hydrazide and alkoxyamide angiogenesis inhibitors
AU2001296448A1 (en)	2002-04-15	Tumor marker and methods of use
EP1225919A4 (en)	2006-07-19	Treatment of cancer
IL141537A0 (en)	2002-03-10	Promotion or inhibition of angiogenesis and cardiovascularization
AU2001268670A1 (en)	2002-01-08	Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of erk-5
AU2001261031A1 (en)	2001-10-30	Inhibition of bone tumor formation using antisense cdna therapy
AU1310201A (en)	2001-04-30	Cdt6 can inhibit angiogenesis and tumor growth, and can induce or enhance the formation of structures containing collagen
IL142742A0 (en)	2002-03-10	Promotion or inhibition of angiogenesis and cardiovascularization
TW422400U (en)	2001-02-11	Improvement of transformer
AU1747100A (en)	2001-04-17	Promotion or inhibition of angiogenesis and cardiovascularization
GB9801391D0 (en)	1998-03-18	Inhibition of cytokine production